“…If other types of highly efficient reactors, for example, roller bottles (Faff et al, 1993), microcarrier reactors (Manousos et al, 1980), packed-bed reactor (Kang et al, 2000), hollow fiber reactors (Boorsma et al, 2002), or other various bioreactors recently reviewed (Merten, 2004), are combined with this circulating strategy with cold reservoir, mass production of high-titer retroviral supernatant is foreseeable. Certainly, such an operating strategy can be extended to clinically acceptable retroviral production systems (e.g., amphotropic retroviruses produced from HEK293-based producer cells) with higher yielding reactors under optimal culture conditions for selected producer cells and viral vectors.…”